CDI Laboratories HuProt v4. 0 Human Proteome Microarrays with Biospecimen Screening Service and Analysis

Award Notice Posted

Solicitation number
75N95025P00168
Agency
Awarded
to CDI Laboratories Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
75N95025P00168 Federal contract award
Place of performance
United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services National Institutes of Health, has awarded contract 75N95025P00168 to CDI Laboratories Inc. for HuProt v4.0 Human Proteome Microarrays with Biospecimen Screening Service and Analysis. The contract, valued at $50,000, was awarded on March 17, 2025, without utilizing a specific set-aside designation. The award was not the result of a competitive solicitation process, and the contract appears to involve specialized scientific research services related to human proteome microarray technology and associated screening and analytical capabilities.

Notice text

The contract was not awarded following the public posting of a combined synopsis/solicitation (non-competitive).

Awarded contract 75N95025P00168 to CDI LABORATORIES INC for 50000.00 on 2025-03-17.

Notice history

Notice Type Posted
This notice Award Award Notice
CDI Laboratories HuProt v4. 0 Human Proteome Microarrays (100) with Biospecimen Screening Service and Analysis Latest solicitation Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
Synthesis and Distribution of Drugs of Abuse and Related Compounds NAICS 541715 National Institute on Drug Abuse No set-aside
Synthesis and Distribution of Drugs of Abuse and Related Compounds NAICS 541715 National Institute on Drug Abuse Total Small Business

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors